AstraZeneca Agrees to Buy Alexion for $39 Billion
AstraZeneca said it agreed to buy Boston-based Alexion for $39 billion in cash and stock, a move that would bolster the British drug...
Full Article
AstraZeneca Agrees to Buy Alexion for $39 Billion
Upworthy
0 shares
1 views
You might like
Related news coverage
AstraZeneca stock price falls sharply on a $39 billion bill to buy Alexion
Invezz
Investors don’t seem impressed with AstraZeneca’s (LON: AZN) latest deal, which is also the biggest deal in the company’s..
-
3 Reasons AstraZeneca's Merger With Alexion Will Work for Investors
Motley Fool
-
Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
SeattlePI.com
-
News24.com | WATCH | AstraZeneca shares dip after $39 billion Alexion deal
News24
-
The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%
Upworthy
Advertisement
More coverage
AstraZeneca to acquire Alexion Pharmaceuticals for £29.50 billion
Invezz
AstraZeneca plc (LON: AZN) said on Saturday that it will buy Alexion Pharmaceuticals (NASDAQ: ALXN) for £29.50 billion. The..
-
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
Upworthy
-
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
Business Insider
-
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Upworthy
-
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. What to Know
Upworthy